BPTF and breast carcinoma: In breast cancer cell lines, BPTF can also inhibit the antitumor activity of NK cells by reducing the cell surface heparan sulfate proteoglycan and natural cytotoxicity receptor co-ligand abundance (Mayes et al., 2017).